FDA Approved Products

4,498 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Active:Lifecycle: LOE ApproachingClear all
TEGRETOL
carbamazepine
LOE Approaching
NovartisNovartis
ORAL · TABLET, CHEWABLE
1981
NDA
30/100
TEGRETOL
carbamazepine
LOE Approaching
NovartisNovartis
ORAL · SUSPENSION
1987
NDA
30/100
TEGRETOL
carbamazepine
LOE Approaching
NovartisNovartis
ORAL · TABLET
1968
NDA
30/100
TEGRETOL-XR
carbamazepine
LOE Approaching
NovartisNovartis
ORAL · TABLET, EXTENDED RELEASE
1996
NDA
30/100
TELEPAQUE
iopanoic acid
LOE Approaching
GH
GE HealthCare
ORAL · TABLET
1951
NDA
30/100
TEMODAR
temozolomide
LOE Approaching
M&
Merck & Co.
ORAL · CAPSULE
1999
NDA
30/100
TEMODAR
temozolomide
LOE Approaching
M&
Merck & Co.
INTRAVENOUS · POWDER
2009
NDA
30/100
TEMOVATE
clobetasol propionate
LOE Approaching
SandozSandoz
TOPICAL · GEL
1994
NDA
30/100
TEMOVATE
clobetasol propionate
LOE Approaching
SandozSandoz
TOPICAL · SOLUTION
1990
NDA
30/100
TEMOVATE
clobetasol propionate
LOE Approaching
SandozSandoz
TOPICAL · OINTMENT
1985
NDA
30/100
TEMOVATE
clobetasol propionate
LOE Approaching
SandozSandoz
TOPICAL · CREAM
1985
NDA
30/100
TEMOVATE E
clobetasol propionate
LOE Approaching
SandozSandoz
TOPICAL · CREAM
1994
NDA
30/100
TENATHAN
bethanidine sulfate
LOE Approaching
ORAL · TABLET
1981
NDA
30/100
TENEX
guanfacine hydrochloride
LOE Approaching
ORAL · TABLET
1986
NDA
30/100
TENORETIC 100
atenolol and chlorthalidone
LOE Approaching
LavipharmLavipharm
ORAL · TABLET
1984
NDA
30/100
TENORETIC 50
atenolol and chlorthalidone
LOE Approaching
LavipharmLavipharm
ORAL · TABLET
1984
NDA
30/100
TENORMIN
atenolol
LOE Approaching
LavipharmLavipharm
ORAL · TABLET
1981
SMNDA
30/100
TENORMIN
atenolol
LOE Approaching
AstraZenecaAstraZeneca
INJECTION · INJECTABLE
1989
SMNDA
30/100
TENSILON
edrophonium chloride
LOE Approaching
R-Pharm USR-Pharm US
INJECTION · INJECTABLE
1951
NDA
30/100
TENSILON PRESERVATIVE FREE
edrophonium chloride
LOE Approaching
R-Pharm USR-Pharm US
INJECTION · INJECTABLE
1951
NDA
30/100
TENUATE
diethylpropion hydrochloride
LOE Approaching
SanofiSanofi
ORAL · TABLET
the management of exogenous obesityhigher
1975
NDA
30/100
TENUATE
diethylpropion hydrochloride
LOE Approaching
ORAL · TABLET
the management of exogenous obesityhigher
1959
NDA
30/100
TENUATE
diethylpropion hydrochloride
LOE Approaching
SanofiSanofi
ORAL · TABLET, EXTENDED RELEASE
the management of exogenous obesityhigher
1975
NDA
30/100
TENUATE DOSPAN
diethylpropion hydrochloride
LOE Approaching
ANI PharmaceuticalsANI Pharmaceuticals
ORAL · TABLET, EXTENDED RELEASE
the management of exogenous obesityhigher
1960
NDA
30/100
← PreviousPage 154 of 188Next →